Article
Antibody–Enzyme Fusion Proteins for Cancer Therapy
1 Feb 2011
Abstract excerpt
Advances in biomolecular technology have allowed the development of genetically fused antibody-enzymes. Antibody-enzyme fusion proteins have been used to target tumors for cancer therapy in two ways. In one system, an antibody-enzyme is pretargeted to the tumor followed by administration of an inactive prodrug that is converted to its active form by the pretargeted enzyme. This system has been described as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
